Long-Term Health-Related Quality of Life (HRQoL) After Redo-Fundoplication.
Journal
World journal of surgery
ISSN: 1432-2323
Titre abrégé: World J Surg
Pays: United States
ID NLM: 7704052
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
accepted:
31
12
2020
pubmed:
28
1
2021
medline:
9
7
2021
entrez:
27
1
2021
Statut:
ppublish
Résumé
We aim to shed light on long-term subjective outcomes after re-operations for failed fundoplication. 1809 patients were operated on for hiatal hernia and/or gastroesophageal reflux disease (GERD) at the Helsinki University Hospital between 2000 and 2017. 111 (6%) of these had undergone a re-operation for a failed antireflux operation. Overall, HRQoL was assessed in 89 patients at the latest follow-up using the generic 15D© instrument. The results were compared to a sample of the general population, weighted to reflect the age and gender distribution of patients. Disease-specific HRQoL was assessed using the GERD-HRQoL questionnaire. We studied variation in the overall HRQoL with respect to disease-specific HRQoL and known patients' parameters using univariate and multivariable linear regression models. The median postoperative follow-up period was 9.3 years. All patients were operated on laparoscopically (6% conversion rate), and 87% were satisfied with the re-operation. Postoperative complications were minimal (5%). Twelve patients (11%) underwent a second re-operation. The median GERD-HRQoL score was nine. In multivariable analysis, four variables were independently associated with the 15D score, suggesting a decrease in the 15D score with increasing GERD-HRQoL score, increasing Charlson Comorbidity Index (CCI) and the presence of chronic pain syndrome (CPS) and depression. Re-do LF is a safe procedure in experienced hands and may offer acceptable long-term alleviation in patients with recurring symptoms after antireflux surgery. Decreased HRQoL in the long run is related to recurring GERD and co-morbidities.
Sections du résumé
BACKGROUND
We aim to shed light on long-term subjective outcomes after re-operations for failed fundoplication.
METHODS
1809 patients were operated on for hiatal hernia and/or gastroesophageal reflux disease (GERD) at the Helsinki University Hospital between 2000 and 2017. 111 (6%) of these had undergone a re-operation for a failed antireflux operation. Overall, HRQoL was assessed in 89 patients at the latest follow-up using the generic 15D© instrument. The results were compared to a sample of the general population, weighted to reflect the age and gender distribution of patients. Disease-specific HRQoL was assessed using the GERD-HRQoL questionnaire. We studied variation in the overall HRQoL with respect to disease-specific HRQoL and known patients' parameters using univariate and multivariable linear regression models.
RESULTS
The median postoperative follow-up period was 9.3 years. All patients were operated on laparoscopically (6% conversion rate), and 87% were satisfied with the re-operation. Postoperative complications were minimal (5%). Twelve patients (11%) underwent a second re-operation. The median GERD-HRQoL score was nine. In multivariable analysis, four variables were independently associated with the 15D score, suggesting a decrease in the 15D score with increasing GERD-HRQoL score, increasing Charlson Comorbidity Index (CCI) and the presence of chronic pain syndrome (CPS) and depression.
CONCLUSION
Re-do LF is a safe procedure in experienced hands and may offer acceptable long-term alleviation in patients with recurring symptoms after antireflux surgery. Decreased HRQoL in the long run is related to recurring GERD and co-morbidities.
Identifiants
pubmed: 33502565
doi: 10.1007/s00268-021-05954-3
pii: 10.1007/s00268-021-05954-3
pmc: PMC8026436
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1495-1502Commentaires et corrections
Type : ErratumIn
Références
PLoS One. 2018 Aug 30;13(8):e0202266
pubmed: 30161169
Surg Endosc. 2014 Jun;28(6):1753-73
pubmed: 24789125
Surg Endosc. 2011 Aug;25(8):2547-54
pubmed: 21512887
J Gastrointest Surg. 2003 Jan;7(1):53-58
pubmed: 12559185
Am J Gastroenterol. 2011 Aug;106(8):1419-25; quiz 1426
pubmed: 21537361
Br J Surg. 2011 Nov;98(11):1581-7
pubmed: 21710482
World J Gastroenterol. 2019 Jan 21;25(3):388-397
pubmed: 30686906
J Visc Surg. 2012 Feb;149(1):e61-5
pubmed: 22317929
Surg Endosc. 2011 Mar;25(3):706-12
pubmed: 20661749
Surg Endosc. 2021 Jan;35(1):298-302
pubmed: 32016514
Surg Endosc. 2003 Jan;17(1):55-60
pubmed: 12239650
Am J Gastroenterol. 2013 Mar;108(3):308-28; quiz 329
pubmed: 23419381
Can J Surg. 2012 Feb;55(1):41-5
pubmed: 22269301
J Gastrointest Surg. 2002 Nov-Dec;6(6):812-8
pubmed: 12504219
Surg Endosc. 2003 Jul;17(7):1042-5
pubmed: 12658416
J Laparoendosc Adv Surg Tech A. 2017 Aug;27(8):755-760
pubmed: 28557566
Qual Life Res. 2015 Mar;24(3):599-606
pubmed: 25145637
Ann Surg. 2021 Dec 1;274(6):e1138-e1143
pubmed: 31913870
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Gut. 2012 Sep;61(9):1340-54
pubmed: 22684483
J Am Coll Surg. 2001 Oct;193(4):428-39
pubmed: 11584971
J Gastrointest Surg. 2008 Feb;12(2):373-81
pubmed: 17846850
Ann Med. 2001 Jul;33(5):328-36
pubmed: 11491191
Gastroenterology. 2008 Oct;135(4):1392-1413, 1413.e1-5
pubmed: 18801365
Curr Gastroenterol Rep. 2019 Jul 25;21(9):41
pubmed: 31346780
J Gastrointest Surg. 2009 Aug;13(8):1539-49
pubmed: 19347410
Ann Surg. 1999 Mar;229(3):331-6
pubmed: 10077044